The excellent outcomes of Luminor were presented at the first day of PVI. First the SOL-Japan trial by Dr Soga, that in 1 year follow-up just 1 patient needed reintervention. Later, TINTIN trial 5-year sugroup analysis by Dr. Deloose, demonstrated that the treatment with Luminor + iVolution pro is the perfect combination for complex and long lesions.
iVascular’s Post
More Relevant Posts
-
How do endophthalmitis rates after IVI differ after using povidone-iodine compared with chlorhexidine? #Retina specialists Drs. Arepalli, Dedania, and Soares review recent literature on the topic: https://bit.ly/49FCyPj
-
Driven Regulatory Affairs professional with over 25 years experience in the Medical Device industry looking for a remote position
Check out these presentations by Matthew Mace from Acorai to learn about the upcoming alternatives in managing Heart Failure.
Exciting news! Our chief scientific officer, Matthew Mace, will present twice today at the Frankfurt CSI congress First up, catch him at the start-up competition in the Pink room at 16:15 CEST. Matthew will be sharing the latest data from the world of Acorai - you won't want to miss it! Immediately following, join Matthew and some esteemed colleagues in the Yellow Room at 17:30 for a session on other device-based heart failure therapies. Make sure to mark your calendars and attend these presentations. Matthew will be in Frankfurt until the end of the congress on Saturday. See you there! #CSIcongress #Acorai #HeartFailureTherapies #FrankfurtPresentation
-
-
Luigi Di Biase, MD, PhD, FACC, FHRS shares his top 3 late-breaking trials from #EHRA2024 Trials discussed include: - Novel Conformable "Single-Shot" PFA Catheter for Pulmonary Vein Isolation - ASTRO - AF: Ablation STrategies for Repeat Procedures in Patients with Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation - Style AF: Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation
EHRA 24: 3 Trials that Will Change My Practice With Dr Luigi Di Biase
https://www.youtube.com/
-
After encountering resistance from an ampullary stricture, see how this physician uses a double-wire cannulation technique to gain biliary access during ERCP. Watch now – then see how Boston Scientific’s new sphincterotome is designed for difficult cannulation: https://bit.ly/3xsCiFX
Have you faced resistance during biliary cannulation? When performing ERCP, this can be a common challenge to gaining access to the bile duct. See how gastroenterologist Dr. Sumit Singla uses a double-wire technique to help a 61-year-old patient with obstructive jaundice and an ampullary stricture – placing one wire in the pancreatic duct and using the second wire to gain access to the biliary tree. Explore more techniques: https://bit.ly/3VVNa9A Dr. Sumit Singla is a paid consultant of Boston Scientific.
-
Resistance isn’t futile. It’s just another common challenge of biliary cannulation. Explore this double-wire technique to gain biliary access for ERCP – and learn how Boston Scientific’s newest sphincterotome can help you manage difficult cannulation: https://bit.ly/4aJlYQd
Have you faced resistance during biliary cannulation? When performing ERCP, this can be a common challenge to gaining access to the bile duct. See how gastroenterologist Dr. Sumit Singla uses a double-wire technique to help a 61-year-old patient with obstructive jaundice and an ampullary stricture – placing one wire in the pancreatic duct and using the second wire to gain access to the biliary tree. Explore more techniques: https://bit.ly/3VVNa9A Dr. Sumit Singla is a paid consultant of Boston Scientific.
-
Did you know that an anastomotic leak can add $24,129 to hospital costs? Intracorporeal anastomosis has been shown to reduce the risk of leaks in right hemicolectomies compared with extracorporeal anastomosis. However, this SPEQ was only completed in 54% of the 389 right hemicolectomies we studied. Get the report to learn more about the study: https://hubs.la/Q02MCm-N0
-
-
This study investigates the feasibility of using QFR in Heart Team discussions for determining optimal revascularization strategies in patients with MVD. It found substantial agreement between the QFR and FFR methods, suggesting that QFR is a viable non-invasive alternative to FFR. This could simplify the decision-making process in clinical settings by reducing reliance on invasive FFR measurements and potentially speeding up procedural times. Taku Asano MD, PhD https://ow.ly/qjN850S3Orv Check out also the Editorial by Patrick W. Serruys; @Pruthvi C. Revaiah 👉 https://ow.ly/pB8550S3OQH
-
-
ENDO and Member Benefits Orientation Recording with Stephen Hammes, MD, PhD If you missed our inaugural member orientation session, the recording can be accessed through our exclusive online community, EndoForum: https://bit.ly/4aGKWj8 Endocrine Society President Stephen Hammes, MD, PhD, introduced our session with topics ranging from ENDO 2024 and how to maximize membership benefits: https://bit.ly/4aGKWj8 #ENDO2024
-
Dr. Nishtha Sodhi Sood (@NishthaSodhi) introduces our latest issue showcasing advanced techniques in contemporary vascular interventions, including mitral, tricuspid, aortic, and pulmonary.
September/October 2024 Issue - Cardiac Interventions Today
citoday.com
-
Today, at the International Symposium of Amyloidosis, we shared positive results of five new analyses of clinical endpoint events from our Phase 3 ATTRibute-CM study of acoramidis in ATTR-CM. Learn more about the insights and emerging real-world evidence in ATTR: https://bit.ly/3KiKqfk
-
Founder of Cable Tubing Solutions GmbH and Consultant for Sommer GmbH part of IS Interconnect Solutions Group
3wCongradulations